Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA. Issue 1 (January 2017)

Record Type:
Journal Article
Title:
Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA. Issue 1 (January 2017)
Main Title:
Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA
Authors:
Bennett, Charles L
Sartor, Oliver A
Armitage, James O
Kantarjian, Hagop
Abstract:
Is Part Of:
Lancet oncology. Volume 18:Issue 1(2017:Jan.)
Journal:
Lancet oncology
Issue:
Volume 18:Issue 1(2017:Jan.)
Issue Display:
Volume 18, Issue 1 (2017)
Year:
2017
Volume:
18
Issue:
1
Issue Sort Value:
2017-0018-0001-0000
Page Start:
22
Page End:
23
Publication Date:
2017-01
Subjects:
Oncology -- Periodicals
Neoplasms -- Periodicals
Cancérologie -- Périodiques
Oncologie
Oncology
Periodicals
Electronic journals
616.994005
Journal URLs:
http://www.sciencedirect.com/science/journal/14702045 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S1470-2045(16)30653-2 ↗
Languages:
English
ISSNs:
1470-2045
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5146.090000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
11158.xml